ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · IEX Real-Time Price · USD
67.11
+0.59 (0.89%)
May 2, 2024, 4:00 PM EDT - Market closed
ANI Pharmaceuticals Employees
ANI Pharmaceuticals had 642 employees on December 31, 2023. The number of employees increased by 42 or 7.00% compared to the previous year.
Employees
642
Change (1Y)
42
Growth (1Y)
7.00%
Revenue / Employee
$758,280
Profits / Employee
$26,720
Market Cap
1.41B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 642 | 42 | 7.00% |
Dec 31, 2022 | 600 | -1 | -0.17% |
Dec 31, 2021 | 601 | 232 | 62.87% |
Dec 31, 2020 | 369 | 31 | 9.17% |
Dec 31, 2019 | 338 | 39 | 13.04% |
Dec 31, 2018 | 299 | 126 | 72.83% |
Dec 31, 2017 | 173 | 30 | 20.98% |
Dec 31, 2016 | 143 | 35 | 32.41% |
Dec 31, 2015 | 108 | 16 | 17.39% |
Dec 31, 2014 | 92 | 11 | 13.58% |
Dec 31, 2013 | 81 | 58 | 252.17% |
Dec 31, 2012 | 23 | -31 | -57.41% |
Dec 31, 2011 | 54 | 9 | 20.00% |
Dec 31, 2010 | 45 | 20 | 80.00% |
Dec 31, 2009 | 25 | 2 | 8.70% |
Dec 31, 2008 | 23 | 12 | 109.09% |
Dec 31, 2007 | 11 | 3 | 37.50% |
Dec 31, 2006 | 8 | -6 | -42.86% |
Dec 31, 2005 | 14 | -3 | -17.65% |
Dec 31, 2004 | 17 | 3 | 21.43% |
Dec 31, 2003 | 14 | 1 | 7.69% |
Mar 1, 2002 | 13 | 6 | 85.71% |
Mar 1, 2001 | 7 | 1 | 16.67% |
Mar 1, 2000 | 6 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
National HealthCare | 13,123 |
Warby Parker | 3,491 |
LeMaitre Vascular | 630 |
Arcus Biosciences | 577 |
Neumora Therapeutics | 124 |
Morphic Holding | 121 |
Akero Therapeutics | 56 |
ANIP News
- 1 day ago - ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences - GlobeNewsWire
- 14 days ago - ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET - GlobeNewsWire
- 23 days ago - ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension - GlobeNewsWire
- 4 weeks ago - ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis - GlobeNewsWire
- 4 weeks ago - ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium - GlobeNewsWire
- 5 weeks ago - ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP - GlobeNewsWire
- 2 months ago - ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 Guidance - GlobeNewsWire
- 2 months ago - ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference - GlobeNewsWire